Maspin, a novel serine protease inhibitor (serpin), suppresses the growth and metastasis of breast tumor in vivo. However, the underlying molecular mechanism is unclear. In the current study, we report the ®rst evidence that endogenous maspin expression in mammary carcinoma cells MDA-MB-435 enhanced staurosporine (STS)-induced apoptosis as judged by the increased fragmentation of DNA, increased proteolytic inactivation of poly-[ADP-ribose]-polymerase (PARP), as well as the increased activation of caspase-8 and caspase-3. In parallel, recombinant maspin did not directly regulate the proteolytic activities of either caspase-3 or caspase-8 in vitro. Consistent with this result, maspin expressing normal mammary epithelial cells underwent more rapid STS-induced apoptosis as compared to breast carcinoma cells. Interestingly, maspin transfectant cells did not undergo spontaneous apoptosis in the absence of STS. Moreover, neither puri®ed maspin protein added from outside nor endogenous maspin secreted to the cell culture media sensitized cells to STS-induced apoptosis. To investigate the structural determinants of maspin in its apoptosis-sensitizing eect, MDA-MB-435 cells were also transfected with maspin/PAI-1 and PAI-1/maspin chimeric constructs resulting from swapping the Nterminal and the C-terminal domains between maspin and PAI-1 (plasminogen activator inhibitor type 1). The resulting stable transfectant clones expressing maspin/ PAI-1 and PAI-1/maspin, respectively, did not undergo spontaneous apoptosis, and were similarly inhibited as maspin transfectant cells in motility assay. Interestingly, however, expression of both maspin/PAI-1 and PAI-1/ maspin in MDA-MB-435 cells failed to sensitize these cells to STS-induced apoptosis. Taken together, our evidence provides new insights into the complex molecular mechanisms of maspin that may suppress breast tumor progression not only at the step of invasion and motility, but also by regulating tumor cell apoptosis. The sensitizing eect of maspin on apoptosis is to be contrasted by the pro-survival eect of several other serpins.
Introduction
Since the identi®cation of the maspin gene (mammary serine protease inhibitor) based on its expression in normal but not in tumor-derived human mammary epithelial cells (Zou et al., 1994) , accumulated functional evidence demonstrates that maspin suppresses tumor metastasis, in part, by inhibiting tumor cell invasion and motility Zhang et al., 1997; Zou et al., 1994) . Maspin protein has a sequence homology with many serpins including plasminogen activator inhibitor-type 1, and -type 2 (PAI-1 and PAI-2). Recent in vitro evidence that maspin inhibits ®brinogen-associated tissue-type plasminogen activator (tPA) and prostate tumor cell surface-associated urokinase plasminogen activator (uPA) (Biliran and Sheng, 2001; McGowen et al., 2000) led to a working hypothesis that maspin inhibits tumor invasion and metastasis by blocking the pericellular plasminogen activation cascade.
Meanwhile, emerging evidence also suggests that the anti-metastasis function of maspin may not be limited to the steps of tumor cell invasion and migration. As compared to the parental mammary carcinoma cells MDA-MB-435 or the mock control cells, stable maspin-expressing transfectant clones produced tumors of signi®cantly reduced sizes at the orthotopic implantation sites in nude mice Zou et al., 1994) . Zhang et al. (2000) subsequently reported that maspin transgene expression in mouse mammary gland inhibited Simian Virus 40 (SV40) large T-antigen induced breast carcinogenesis, and correlated with increased programmed cell death, or apoptosis. Independent in vitro study of Li et al. (1998) showed that apoptosis induced by manganese-containing superoxide dismutase was associated with elevated maspin expression level. These results led to the speculation that maspin may also play a role in apoptosis. It is important to bear in mind, however, that normal mammary epithelial cells that express high level of maspin do not undergo detectable apoptosis either in vivo or in vitro. Moreover, maspin neither alters the growth kinetics of a variety of breast epithelial cell lines, nor directly induces apoptosis in vitro (Shao et al., 1998; Sheng et al., 1994 Sheng et al., , 1996 . Thus, the maspin eect on apoptosis may be a part of cellular response to speci®c pathological or pharmacological apoptotic stimuli.
In this study, we showed that maspin re-expression in breast carcinoma cells is not sucient to induce apoptosis in vitro. However, it sensitizes cells to staurosporine (STS)-induced apoptosis, which is mediated, at least in part, by the caspase-8/caspase-3 pathway. Interestingly, maspin reactive site loop (RSL) sequence that has been shown to play a critical role in the maspin eect on tumor cell invasion/motility and on plasminogen activation (Biliran and Sheng, 2001; McGowen et al., 2000; Sheng et al., 1994 Sheng et al., , 1996 Sheng et al., , 1998 appeared to be essential but not sucient for the maspin eect in sensitizing cells to induced apoptosis. Taken together, our data suggests that maspin may regulate tumor cell apoptosis by a distinct mechanism. This study provides exciting new insights into the functional complexity, and the potential application of tumor suppressive maspin for enhancing the ecacy of chemotherapeutic agents.
Results

Maspin sensitizes MDA-MB-435 cells to staurosporineinduced apoptosis
Maspin has been shown to inhibit tumor cell invasion and motility (Seftor et al., 1998; Sheng et al., 1996; Zhang et al., 1997; Zou et al., 1994) . The evidence that maspin expression correlates with increased sensitivity of mammary epithelial cells to apoptosis (Li et al., 1998; Shao et al., 1998; Zhang et al., 1999 Zhang et al., , 2000 raised the possibility that the maspin eect on tumor cell motility/ invasion may result from an increased cell apoptosis. To address this possibility, stable maspin transfectant clones derived from mammary carcinoma cells MDA-MB-435, Tn15 and Tn16, along with a mock transfectant clone pCIneo were ®rst examined in parallel by motility assay and by caspase-3 activity assay. The motility of Tn15 and Tn16 was inhibited by at least sevenfold compared to parental MDA-MB-435 and the pCIneo control clone ( Figure 1A ). This result was in good agreement with an earlier report . Under the same culture condition, all cell lines tested were not apoptotic and exhibited similar negligible level of caspase-3 activities ( Figure 1B) .
To test whether maspin plays a role in induced apoptosis, staurosporine (STS), a strong protein kinase C inhibitor and a well-studied apoptosis inducer (Gomez-Angelats et al., 2000; Jacobsen et al., 1996; Tamaoki et al., 1986; Tang et al., 2000) , was used to induce apoptosis. The apoptotic eect of STS was ®rst evaluated by a modi®ed TdT-mediated dUTP NickEnd Labeling (TUNEL) assay. When the mock control cells were treated with STS in the range of 0.5 ± 2 mM for 24 h, a dose-dependent apoptosis was observed. In all subsequent experiments, cells were treated with 0.5 mM STS, a minimum concentration to induce detectable DNA fragmentation in the pCIneo cells. As shown in Figure 2 , after the treatment for 24 h, the pCIneo cells showed signi®cant shrinkage that is typical for STS-induced apoptosis (Gomez-Angelats et al., 2000; Jacobsen et al., 1996; Tang et al., 2000) . However, only a small fraction (10+2.4%) of this cell population gave rise to a detectable TUNEL reactivity. In parallel, STS treatment of maspin-expressing transfectant clone Tn15 led to not only cell shrinkage, but also a high level of DNA fragmentation in 54+5.5% of the total cell population. STS treated Tn16 and three other maspin transfectant clones exhibited a TUNEL reactivity comparable to that of STS treated Tn15 (data not shown). Interestingly, normal mammary epithelial cells 70N that express maspin at a high level (Zou et al., 1994) were even more sensitive to STS-induced apoptosis than Tn15 (and Tn16) cells. In fact, treatment of 70N cells with 0.5 mM STS for 24 h lead to complete cell detachment and death (data not shown). When treated with 0.5 mM Figure 1 The Eect of endogenous maspin on the motility and caspase-3 activity of breast carcinoma MDA-MB-435 cells. (A) In vitro cell motility assay. Cell motility is presented as the total number of cells that migrated across the matrigel-coated polycarbonate ®lters. Data represent the average of three parallel experiments and the error bars represent the standard errors. (B) Caspase-3 activity assay. Cells were seeded and collected under the same culture condition as in motility assay. The caspase-3 activity (¯uorescence unit) in each sample was normalized by caspase-3 activity of parental MDA-MB-435 cells. The data represent the average of three parallel experiments and the error bars represent the standard errors STS for 12 h, 70N cells remained largely adherent, but showed a high level of DNA fragmentation, comparable to that found in STS-treated Tn15 cells (for 24 h).
To verify the dierential DNA fragmentation patterns among dierent cell lines at the molecular level, total DNA was isolated from pCIneo cells and maspin transfectant clones. As shown in Figure 3A , little or no DNA fragmentation was detected in all untreated cell lines. STS treatment led to marginal DNA fragmentation in pCIneo cells. In contrast, STStreated Tn15 (and Tn16, data not shown) and 70N cells gave rise to fragmented DNA at a signi®cantly elevated level. Western blot analysis showed ( Figure  3B ) that pCIneo cells, both untreated and STS-treated, expressed no detectable maspin. On the other hand, the constitutively expressed maspin in transfectant clones was not altered by STS-induced apoptosis.
A hallmark of cellular response to apoptotic DNA fragmentation is the inactivation of poly-[ADP-ribose]-polymerase (PARP), an enzyme that catalyzes nuclear protein ribosylation and facilitates DNA damage repair (Bromme and Holtz, 1996) . The inactivation of the 116 kDa PARP is carried out by speci®c proteolytic cleavage, yielding an 85 kDa PARP fragment (Boulares et al., 1999; D'Amours et al., 1998) . As shown in Figure 3B , the conversion of PARP from 116 to 85 kDa was signi®cantly increased in Tn15 and Tn16 cells as compared to that in pCIneo cells. This data further con®rms that maspin expression indeed sensitized cells to STS-induced cell death via an apoptotic mechanism. Taken together, endogenous maspin expression was not sucient to cause spontaneous cell death. However, it sensitized MDA-MB-435 cells to STS-induced apoptosis.
The maspin effect on STS-induced caspase-8/caspase-3 activation Agarose gel electrophoresis of DNA ladder. Lane 1 shows the DNA molecular weight marker. Samples 2 ± 6 represent DNA isolated from untreated and STS-treated pCIneo, Tn15, Maspin/ PAI-1 clone #12, PAI-1/maspin transfectant clone #5, and normal mammary epithelial cells 70N, respectively. A total of 10 mg of DNA was loaded into each lane. (B) Western blotting of PARP and maspin. Cells were incubated in serum-free medium in the presence or absence of STS for 24 h, and then lysed. A total of 100 mg of lysate protein from each cell line was resolved by SDS ± PAGE and transferred to PVDF membrane, which was then probed with speci®c antibodies against PARP. The same blot was stripped and re-probed with the speci®c antibody against maspin. To assess the loading normality, the same blot was subsequently re-probed with the antibody against b-actin pCIneo cells started to increase 30 min after the STStreatments and reached maximum activity after 7 to 8 h. In parallel, maspin transfectant clones exhibited a greatly enhanced activation of caspase-3. As shown in Figure 4A , 4 h after the STS treatment, the caspase-3 activity in Tn15 and Tn16 was at least ®vefold higher than that in pCIneo cells. This response was repeatedly shown in three other maspin transfectant clones (data not shown).
Caspase-3 is a cysteine protease. To test whether maspin protein directly regulates the activity of caspase-3, puri®ed recombinant rMaspin was added up to 200 nM to the caspase-3 activity assay mixtures containing the lysate of pCIneo (or MDA-MB-435, data not shown). As shown in Figure 4B , rMaspin did not have any signi®cant eect on either the basal level or the STS-induced caspase-3 activity. Thus, it is unlikely that maspin directly stimulated caspase-3 activity. On the other hand, since neither the level nor the integrity of the constitutively expressed maspin in transfectant clones was altered by STS-induced apoptosis ( Figure 3B ), it is also unlikely that maspin acted as a substrate of caspase-3 or other intracellular proteolytic enzymes.
It is thought that caspase-3 can be proteolytically cleaved and activated by caspase-8 (Budihardjo et al., 1999) . To test whether maspin sensitized-apoptosis involved this speci®c caspase activation pathway, caspase-8 activity in cell lysates were analysed using a caspase-8 speci®c¯uorogenic substrate. As shown in Figure 4C , pCIneo cells exhibited an increase of caspase-8 activity as soon as 2 h after the STStreatment. As compared to pCIneo cells, maspin transfectant cells underwent a signi®cantly faster caspase-8 activation ( Figure 4C ). Thus, maspin appears to facilitate an upstream event that leads to caspase-8/ caspase-3 activation.
Extracellular maspin is not essential for sensitizing cells to STS-induced apoptosis
Maspin expressed in Tn15 and Tn16 cells was also detected in the conditioned culture media (CM, Figure  5A ). Moreover, previous functional studies suggest that pericellular maspin was active in inhibiting tumor cell motility and invasion (Seftor et al., 1998; Sheng et al., 1996) . To test whether secreted maspin was responsible for sensitizing STS-induced apoptosis, pCIneo cells were treated by STS in the presence of the CM of either maspin transfectants or pCIneo cells. As shown in Figure 5B , the STS-induced apoptosis as measured by caspase-3 activity (as well as caspase-8 activity, data not shown) was not signi®cantly aected in each case. In parallel, parental MDA-MB-435 cells were treated with STS in the presence or absence of puri®ed recombinant rMaspin at a ®nal concentration of 200 nM. As shown in Figure 5C , rMaspin neither induced apoptosis by itself, nor aected the STSinduced apoptosis. Thus, it is likely that intracellular or cell-associated, rather than extracellular soluble, maspin sensitized cells to STS-induced apoptosis. Maspin has an overall homology with many inhibitory serpins (Zou et al., 1994) . However, maspin reactive site loop (RSL) sequence is somewhat deviant from that of the bona ®de inhibitory serpins such as PAI-1 and PAI-2 (Lawrence, 1997; Travis et al., 1990) . In an attempt to investigate the sequence determinants in maspin responsible for sensitizing cells to induced apoptosis, two chimeras named as maspin/PAI-1 and PAI-1/ maspin, were constructed using the scheme as illustrated in Figure 6A . In PAI-1/maspin construct, maspin RSL (amino acids 331 ± 346) plus 30 downstream amino acids at its C-terminus terminus was replaced by the corresponding sequence of PAI-1 (amino acids 356 ± 402). In maspin/PAI-1 construct, the maspin Nterminus containing 330 amino acids was replaced by the ®rst 355 amino acids of PAI-1. The sequence of the ®rst 330 amino acids of maspin is 36% homolog with the corresponding fragment of PAI-1. Maspin RSL and PAI-1 RSL (amino acids 356 ± 374) bear 0% homology. The C-terminal 28 amino acids of PAI-1 (down-stream of its RSL) have a sequence 67% identical to the corresponding fragment of maspin (Zou et al., 1994) .
Multiple stable maspin/PAI-1 and PAI-1/maspin transfectant clones derived from MDA-MB435 cells, respectively, were selected based initially on their resistance to G418. RT ± PCR using the chimeraspeci®c primers con®rmed the expression of maspin/ PAI-1 (Figure 6Ba ) and PAI-1/maspin (Figure 6Ca) at the mRNA level. Western blotting using a maspinspeci®c antibody detected a 42 kDa protein in the cell lysates of all the maspin/PAI-1 transfectant clones tested, but not in the mock control cells (Figure 6Bc ). The chimeric PAI-1/maspin protein could not be detected by any maspin-speci®c antibodies that were available (data not shown), but was detected in the transfectant clones but not in the mock clones by a monoclonal antibody against PAI-1 (Figure 6Cb ). The detected PAI-1/maspin protein was slightly smaller than wild type PAI-1.
It has been shown that the inhibitory activity of maspin on cell motility is consistent with its inhibitory eect on cell surface-associated uPA (Biliran and Sheng, 2001; McGowen et al., 2000) . Since PAI-1 also inhibits cell surface-associated uPA and cell motility (for review see Andreasen et al., 2000; Blasi, 1999) , the chimeras resulting from the domain-speci®c swapping between the N-terminal and the C-terminal domains of maspin and PAI-1 are likely to act as protease inhibitors and be able to block cell migration. Indeed, as shown in Figure 7A , maspin/PAI-1 and PAI-1/ maspin transfectant cells were signi®cantly inhibited in cell migration assay, both to a similar extent as maspin transfectant cells (approximately 60 ± 80%). However, when multiple maspin/PAI-1 and PAI-1/maspin clones were treated with STS and subsequently analysed by TUNEL assay, all these transfectant clones showed a signi®cantly reduced sensitivity towards STS-induced apoptosis as compared to maspin transfectant cells. In fact, both maspin/PAI-1 and PAI-1/maspin clones behaved similarly as the mock control cells ( Figure  2) . Results obtained from parallel DNA-ladder experiment ( Figure 3A ) and caspase-3 activity assay ( Figure  7B ) further showed that maspin/PAI-1 and PAI-1/ maspin transfectant clones were neither inhibited, nor further stimulated in STS-induced apoptosis. This data suggests that although the role of maspin in inhibiting pericellular proteolysis and cell motility may be redundant to that of an inhibitory serpin such as PAI-1, the unique apoptosis-sensitizing eect of maspin appears to depend on the integrity of its entire sequence and, thus, its overall conformation.
Discussion
The purpose of the current study is to investigate the role of maspin in mammary tumor cell apoptosis. We Figure 5 The eect of extracellular maspin on STS-induced apoptosis. (A) Detection of secreted maspin. Fifty micrograms of protein from the concentrated SF-CM of pCIneo or maspin transfectants (Tn15 and Tn16) were subjected to Western blotting using a maspin-speci®c antibody. (B) The eect of extracellular maspin on STS-induced caspase-3 activation. pCIneo cells cultured in the media that was pre-conditioned by pCIneo, Tn15 and Tn16 cells, respectively, were either left untreated or treated with STS for 24 h. The resulting cell lysates were analysed by caspase-3 activity assay. The caspase-3 activity (¯uorescence production) in each sample was expressed as a fold increase compared to that obtained with untreated pCIneo cells cultured in their own conditioned media. (C). The eect of puri®ed rMaspin on STS-induced caspase-3 activation. MDA-MB-435 cells were induced by STS in the presence or absence of 200 nM rMaspin for 24 h. The resulting cell lysates were analysed by caspase-3 activity assay. The caspase-3 activity (¯uorescence production) in each sample was expressed as a fold increase compared to that obtained with untreated cells in the absence of rMaspin. In both (B) and (C), the data represent the average of three parallel experiments and the error bars represent the standard errors showed that maspin alone was not sucient to induce apoptosis. However, we showed for the ®rst time that maspin greatly sensitized breast carcinoma cells MDA-MB-435 to STS-induced apoptosis. Furthermore, the apoptosis-sensitizing eect of maspin appears to depend on its overall sequence. These data not only help explain the earlier observation that overexpression of maspin correlates with increased apoptosis under certain conditions (Li et al., 1998; Shao et al., 1998; Zhang et al., 1999 Zhang et al., , 2000 , but also provide exciting new leads regarding the complex tumor suppressive modes of maspin action.
Considering the evidence that maspin is abundantly expressed in normal mammary epithelial cells (Zou et al., 1994) and that maspin expression is increased at several non-apoptotic stages of mammary gland development in a murine model, i.e., puberty, pregnancy and lactation (Zhang et al., 1997) , it was not surprising that maspin re-expression in MDA-MB-435 cells alone did not cause spontaneous cell death in culture. On the other hand, since several other serpins implicated in apoptosis primarily regulate inducedapoptosis (Dickinson et al., 1995; Kanamori et al., 2000; Kwaan et al., 2000; Schleef and Chuang, 2000) , the negligible eect of maspin on the growth and survival of MDA-MB-435 cells in maintenance culture may be a manifestation in an environment that lacks appropriate apoptotic stimuli.
Indeed, as shown in this study, an apoptosis-sensitizing eect of maspin was only evident when cells underwent STS-induced apoptosis.
STS is a strong inhibitor of protein kinase C (PKC) and has been shown to induce apoptosis (GomezAngelats et al., 2000; Jacobsen et al., 1996; Tamaoki et al., 1986; Tang et al., 2000) , at least in some breast tumor cells, at a step upstream of caspase-8 (Tang et al., 2000) . This notion is supported by the evidence that protein kinase C protects against cell death mediated by Fas ligand that speci®cally activates the caspase-8/caspase-3 pathway (Chen et al., 2001) . In this study, we showed that endogenous maspin expression further enhanced the STS-induced activation of caspase-8 and caspase-3, proteolytic inactivation of PARP, as well as DNA fragmentation. Consistent with this observation, normal mammary epithelial cells 70N that express a high level of maspin were signi®cantly more sensitive to STS-induced apoptosis as compared to mammary carcinoma cells MDA-MB-435 that do not express maspin. Taken together, our data suggests that maspin may sensitize STS-induced apoptosis by enhancing the eciency of the activated apoptosis cascade. While the choice of STS helped simplify the experimental system and address the eect of maspin on a major apoptosis pathway, it has been noted that the role of a serpin in apoptosis may depend on the speci®c genetic background of the cells as well as the The expression of the maspin/PAI-1 chimera in MDA-MB-435 derived stable transfectant clones was detected by RT ± PCR (a). Parallel RT ± PCR for the housekeeping gene GAPDH was performed to assess the loading normality (b). The maspin/PAI-1 chimera protein in the cell lysates was detected by Western blotting using a monoclonal antibody against maspin (c) (50 mg of protein/lane). In (a ± c), lane 1 represents samples from a pCIneo clone, while lanes 2 ± 7 represent samples from maspin/PAI-1 transfectant clones #2, #5, #7, #8, #10, and #12, respectively. (C) The expression of PAI-1/maspin chimera in MDA-MB-435 derived stable transfectant clones was detected by RT ± PCR (a). The PAI-1/Maspin chimera protein in the cell lysates was also detected by Western blotting using monoclonal antibody EGG against PAI-1 (b). In (a) and (b), lane 2 represents samples from a pCIneo clone, while lanes 3 ± 5 represent samples from PAI-1/maspin transfectant clones #5, #6 and #12, respectively. Lane 1 in (a) shows the molecular markers of DNA (from top to bottom: 23, 9.5, 6.5, 4.3, 2.3 and 2.0 kb). Lane 1 in (b) was loaded with 0.5 mg of recombinant PAI-1. In (B) and (C), equal loading of Western blots was veri®ed by re-probing the membranes with b-actin antibody (data not shown) speci®c apoptotic stimuli. For example, the viral serpin CrmA (cytokine response modi®er A). protects cells from induced apoptotic in some cases (Los et al., 1995; Miura et al., 1993 Miura et al., , 1995 , but occasionally sensitizes cells to induced cell death (Vercammen et al., 1998) . Thus, it is of key importance for the future study to identify the biological or pathological apoptosis stimuli that are regulated by maspin.
The role of maspin in cell apoptosis may be distinct from that in tumor cell invasion and motility. It has been noted that endogenous maspin is found in cytoplasm, on the cell surface as well as in conditioned culture media (Pemberton et al., 1997; Shao et al., 1998; Sheng et al., 1996) . The inhibitory eect of maspin on cell invasion and motility is localized primarily on the cell surface and in pericellular space . However, in this study, we found that the addition of maspin-containing conditioned medium or recombinant maspin to pCIneo cells or MDA-MB-435 cells did not have any signi®cant eect on STS-induced apoptosis ( Figure 5 ). This data suggests that extracellular maspin may not be directly involved in regulating induced-apoptosis. Conversely, the intracellular maspin appears to be responsible for its sensitizing eect on induced-apoptosis. This ®nding is in line with a report that intracellular PAI-2, rather than secreted PAI-2, contributes to the protection of HeLa cells from TNF-a-induced apoptosis in (Dickinson et al., 1998) .
Alternatively, in view of the accumulated evidence for a role of uPA and its receptor uPAR in regulating integrin-mediated cell survival (for review see Ossowski and Aguirre-Ghiso, 2000) , and our earlier evidence that endogenous expression of maspin led to a dramatic decrease both in cell surface uPA activity and in cell surface-associated uPA and uPAR proteins (Biliran and Sheng, 2001) , it remains a possibility that maspin may sensitize induced apoptosis by reducing cell surface-associated pro-survival uPA/uPAR complex. In addition, future studies are needed to address whether the biological function of secreted maspin may subsequently feed back the function of intracellular of cell-associated maspin. Vice versa, the maspin eect on induced-apoptosis may eventually reduce the invasive and migratory activity of tumor cells. It is conceivable that intracellular and extracellular maspin co-exist in equilibrium in vivo. Furthermore, the biological function of intracellular and extracellular maspin may be delicately balanced by protein tracking.
Serpins share a generally conserved sequence and structural framework (Potempa et al., 1994) . Interestingly, unlike several serpins such as PAI-1 (Kwaan et al., 2000) , PAI-2 (Dickinson et al., 1995) , PI-9 (Kanamori et al., 2000) , and PI-10 (Schleef and Chuang, 2000) , that have an anti-apoptosis eect, maspin has an apoptosis-sensitizing eect. This maspin eect, therefore, may be dictated by unique elements in its sequence. The current study showed that both maspin/PAI-1 and PAI-1/maspin transfectant clones were signi®cantly inhibited in cell motility ( Figure 7 ) and invasion (data not shown) assays. Since the inhibitory eect of maspin on tumor cell motility and invasion correlates with its inhibitory eect on cell surface-associated uPA (Biliran and Sheng, 2001; McGowen et al., 2000) , it is likely that the maspin/ PAI-1 and PAI-1/maspin chimeras resulting from swapping the N-terminuses and C-terminuses (containing the RSL sequence) between maspin and the wellcharacterized anti-proteolytic serpin PAI-1 did not alter the general structural framework that supports the proteolytic inhibitory activity. While more detailed studies are underway to investigate the role of maspin/ PAI-1 and PAI-1/maspin on pericellular plasminogen activation, it is of particular importance to note that neither maspin/PAI-1 nor PAI-1/maspin transfectant clones were sensitized to STS-induced apoptosis. Moreover, maspin depended not only on its proteolytic inhibitory potential, but also on the integrity of its overall sequence to sensitize cells to induced apoptosis. This evidence indicates that the maspin eect on induced apoptosis may not be redundant to that of other serpins such as PAI-1.
To date, the intracellular targets, thus the molecular modes of action, of serpins involved in apoptosis are unknown. The possibility remains that maspin may sensitize induced apoptosis by inhibiting an intracellular protease. To this end, Biswas et al. (2001) have shown that Go6976, an STS-derived compound that speci®cally inhibits PKC a-and b-subunits, induces the apoptosis of ER-negative breast carcinoma cells through the inhibition of NF-kB activity. Considering the evidence that NF-kB is primarily activated by the ubiquitin-mediated degradation of IkB, a cytosolic inhibitor of NF-kB in its p105 precursor (Lee and Goldberg, 1998; Palombella et al., 1994) , it is intriguing to hypothesize that maspin may enhance STS-induced inactivation of NF-kB by blocking the proteolytic degradation of IkB.
On the other hand, considering an earlier evidence that the antiproteolytic activity of PAI-2 was not essential for its anti-apoptotic function (Dickinson et al., 1998) , we cannot rule out the possibility that maspin may sensitize cells to induced apoptosis by interacting with an intracellular cognate molecule in a non-inhibitory manner. Based on the novel RSL sequence of maspin, Hopkins and Whisstock (1994) speculated that maspin might interact with a thymosin b-4 like molecule that has no proteolytic activity. While this possibility needs to be further investigated, it is important to note that b-thymosins are a family of small acidic cytoplasmic polypeptides. Beta-4 and b-10 thymosins have been shown to sequester actin and regulate F-actin assembly (Yu et al., 1993) . Furthermore, thymosin b-10 has been shown to accelerate TNF-a induced ®broblast apoptosis (Hall, 1995) .
In summary, this is the ®rst report that endogenous maspin sensitized cells to induced apoptosis in vitro. Together with our earlier evidence, these results suggest that maspin may suppress breast tumor metastasis by two distinct mechanisms: (i) inhibiting tumor cell invasion and motility by neutralizing pericellular proteolytic activities, and (ii) sensitizing tumor cells to induced apoptosis. Extensive studies are underway to evaluate the eect of maspin on induced apoptosis of other types of cells.
Materials and methods
Cell culture and reagents
Breast carcinoma cell line MDA-MB-435 was obtained from American Type Culture Collection (Rockville, MD, USA) and maintained in a-MEM (Life Technologies Inc., NY, USA) supplemented with 5% fetal calf serum (FCS) (Hyclone, UT, USA). Stable maspin transfectant clones (Tn 15 and Tn16) and the mock transfectant clone (pCIneo) derived from MDA-MB-435 cells were generated and cultured as described . Normal mammary epithelial cells 70N were culture in DFCI-1 medium (Band and Sager, 1989) . Recombinant maspin was overexpressed in Baculo-virus infected insect cells Sf9, and was puri®ed as previously described . All other chemicals, unless otherwise speci®ed, were obtained from SIGMA (St. Louis, MO, USA) in the highest suitable purities. All oligonucleotides were customer-designed and synthesized by Life Technologies Inc.
Construction and endogenous expression of maspin/PAI-1 and PAI-1/maspin chimeras For the construction of maspin/PAI-1, a DraIII cloning site was generated by PCR at the position 11 amino acids upstream from the PAI-1 P 1 P 1 ' peptide bond. A 3'-terminal EcoRI cloning site was created down-stream of PAI-1 translation stop codon. The primers used were 5'-GCTGCA-CAAAGTGAAGATCGAGGTGAACG-3' and 5'-CCGAA-TTCAAAGGTCCTCCAAGGAGAGG-3', respectively. The 5'-DraIII to 3'-EcoRI fragment of this C-terminal domain of PAI-1 was then ligated to the N-terminal fragment of maspin cDNA generated by EcoRI/DraIII double digestion of the pBluescript/maspin plasmid cDNA (Zou et al., 1994) . DNA sequencing (Pathology Laboratory, WSU, USA) con®rmed that the maspin/PAI-1 construct contained 330 N-terminal amino acids of wild type maspin and 47 amino acids of the C-terminal domain of wild type PAI-1. The full-length maspin/PAI-1 coding sequence was subcloned into a mammalian expression vector pCIneo (Promega, WI, USA) to generate pMaspin/PAI-1 plasmid.
For the construction of PAI-1/maspin, an EcoRI cloning site was engineered immediately upstream of the 5' terminus of wild type PAI-1 cDNA. A DraII I cloning site was generated by PCR at the position 15 amino acids upstream from the PAI-1 P 1 P 1 ' peptide bond. The primers used were 5'-CCGAATTCGCAAGGCACCTCTGAGAACT-3' and 5'-CTTCACTTTGTGCAGCGCCTGCGC-3', respectively. The 5'-EcoRI to 3'-DraIII fragment of this N-terminal domain of PAI-1 was then ligated to the C-terminal fragment of maspin cDNA generated by DraIII/Xbal double digestion of the pBluescript/maspin plasmid cDNA (Zou et al., 1994) . DNA sequencing (Pathology Laboratory, WSU, USA) con®rmed that the maspin/PAI-1 construct encodes 355 N-terminal amino acids of wild type PAI-1 followed by 46 amino acids of the C-terminal domain of wild type maspin. The full length PAI-1/maspin coding sequence was subcloned into a mammalian expression vector pCIneo (Promega, WI, USA) to generate pPAI-1/maspin plasmid.
To express endogenous maspin/PAI-1 and PAI-1/maspin chimeras, MDA-MB-435 cells were transfected with pMaspin/PAI-1, pPAI-1/maspin, and pCIneo vector DNA, respectively, using an electroporation procedure Zou et al., 1994) . Brie¯y, approximately 1610 7 MDA-MB-435 cells harvested in log phase were electroporated with 40 mg of each plasmid DNA at 250V and 960 microfarads in a-MEM containing 5% FCS. The electroporated cells were cultured in 24-well plates in a-MEM supplemented with 5% FCS and 1 mg/ml geneticin (or G418, Life Technologies Inc.) for 14 days. The surviving individual clones were chosen using cloning rings (Bel-Art Products, NJ, USA), and maintained routinely in the presence of 500 mg/ml geneticin. Twenty individual clones were expanded for each transfection reaction.
Reverse transcription-PCR
Total RNA was extracted from cells using the RNeasy Mini Kit (Qiagen). The extracted RNA was reverse-transcribed with the AMV reverse transcriptase (Promega) in the presence of oligo(dT) 15 primer as described by the manufacturer. The resulting cDNA preparation was subjected to PCR ampli®cation using template-speci®c upstream and downstream primers for 25 cycles. Each PCR cycle included a denaturation step at 948C for 30 s; a primer-annealing step at 558C for 45 s (maspin, or maspin/PAI-1, or PAI-1/ maspin), or at 628C for 1 min (GAPDH); and an extension step at 728C for 45 s. Reactions were performed in a Genius programmable thermal controller model (Techne Incorporated, Duxford, Cambridge). The primers used for PCR ampli®cation of maspin/PAI-1 were 5'-GCGAATTCGGCT-TTTGCCGTTGATCTGT-3' and 5'-CCGAATTCGAAGG-TCCTCCAAGGAGAGG-3'. The expected PCR product is about 1200 base pairs of size. The primers sued for PCR ampli®cation of PAI-1/maspin were 5'-CCGAATTCGCAA-GGCACCTCTGAGAACT-3' and 5'-CTTCATGAAGCCT-GTGGACTCATCCTC-3'. The primers used for GADPH PCR ampli®cation were 5'-ACGGATTTGGTCGTATTG-GG-3' and 5'-TGATTTTGGAGGGATCTCGC-3'. The PCR products were analysed by electrophoresis on 1% agarose gel containing ethidium bromide, and photographed under UV light.
Western blotting
For Western blotting of cell lysates, cells were collected using a cell scraper and lysed in a low-salt, protease inhibitor-rich lysis buer . A total of 100 mg soluble protein extracted from each transfectant clonal cell line was resolved by 10% SDS ± PAGE. For Western blotting of conditioned media (CM), CM were collected upon 24 h incubation of keratinocyte serum free medium (K-SFM) (Life Technologies Inc.), and concentrated approximately 100-fold using Centricon YM-10 concentrators (Millipore, MA, USA). A total of 50 mg soluble protein from each CM sample was applied to 10% SDS ± PAGE. Western blotting was performed with monoclonal antibody to maspin (Pharmingen), or monoclonal antibody EGG to PAI-1 (DuPont Merck), or poly(ADP-ribose) polymerase (PARP) (Pharmacia) or b-actin (Pharmacia), and the corresponding horse radish peroxidaseconjugated secondary antibodies. Immunoreactivity was detected using the enhanced chemiluminescence reagent from Amersham.
Induced apoptosis
Cells cultured in 6-well plates for 24 h were incubated with 0.5 mM STS at 378C with 6.5% CO 2 for indicated hours. To test the eect of secreted maspin, STS was added to the cells that had been cultured for 24 h in the K-SFM preconditioned (for 24 h) by maspin transfectants or pCIneo cells. To examine the eect of puri®ed recombinant human maspin (rMaspin) cells were incubated with rMaspin at a ®nal concentration of 20 ± 200 nM for 24 h prior to the addition of STS.
TUNEL assay and electrophoresis assays for DNA fragmentation
To detect DNA fragmentation at the cellular level, cells were seeded in 8-well Lab-Tek 1 II chamber slides at a density of 100 000/well and incubated for 24 h in the corresponding maintenance media. The cells were treated with 0.5 mM STS 24 h (with the exception of 12 h for 70N cells), washed twice with PBS and ®xed with freshly prepared 4% paraformaldehyde at room temperature for 25 min. The cells were washed and permeabilized in 0.2% Triton X-100 (in PBS) for 5 min at room temperature. The cells were then washed and stained by a modi®ed TUNEL procedure using the DeadEnd TM Colorimetric Apoptosis Detection System (Promega, Madison, WI, USA). To detect DNA fragmentation at the molecular level, cells were seeded in 60 mm petri dishes at a density of 2610 6 /dish and incubated in the corresponding media for 24 h before the STS treatments. DNA isolated from either STS-treated of untreated cells using the Apoptotic DNA ladder Kit (Roche Diagnostics GmbH, Mannheim, Germany) were analysed by 1% agarose gel electrophoresis and visualized by ethidium bromide¯uorescent staining.
Caspase activity assays
For caspase-3 activity assay, cells were treated with STS for 4 h. For caspase-8 activity assay, cells were treated with STS for 2 h. Following the removal of detached cells by aspirating the culture media, the remaining adherent cells were lysed in 200 ml of 50 mM Tris buer (pH 7.5) containing 0.05% Nonidet and 1 mM DTT. The clear supernatant (cytosolic fraction) resulting from the centrifugation at 12 000 g for 5 min at 48C was collected. A total of 25 mg protein from each cytosolic fraction was incubated with 40 mM peptide substrate for caspases-3, or -8 for 120 min at 378C in 200 ml reaction mixtures containing 10 mM HEPES (pH 7.5), 50 mM NaCl, and 2.5 mM DTT. The peptide substrates for caspases-3 and -8 were Ac-DEVD-AMC and Ac-IETD-AMC, respectively (International Bio, CA, USA). To test the eect of puri®ed maspin on caspase-3 activity, rMaspin was added at 20 ± 200 nM ®nal concentrations along with the¯uorogenic substrate of caspase-3 into the assay mixtures. Fluorescence released by caspase activity was measured at 380 nm excitation and 460 nm emission using the SPECTRAmax GEMINI spectro¯uorometer (Molecular Devices, CA, USA). The cytosolic fractions of untreated cells were analysed in parallel and were used as the background.
In vitro Motility Assay Using Membrane Invasion Culture System (MICS) was performed as previously described .
